Clinical Trial: A Study of CGRP Monoclonal Antibody to Treat Diabetic Neuropathy
Study Status: Completed
Recruit Status: RECRUITING
Condition: Diabetic Polyneuropathy
Study Type: INTERVENTIONAL
Official Title: CAT-Trial: CGRP Monoclonal Antibody for Treatment of Painful Diabetic Neuropathy: a Double-blind, Randomized, Placebo-controlled, International Multicenter, Phase II Clinical Trial
Brief Summary:
The main purpose of this study is to compare the change in pain intensity during treatment with a CGRP monoclonal antibody (eptinezumab) compared with placebo treatment in patients with painful diabetic polyneuropathy (DPN).
Read more